Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities.

Pallud J, Varlet P, Devaux B, Geha S, Badoual M, Deroulers C, Page P, Dezamis E, Daumas-Duport C, Roux FX.

Neurology. 2010 May 25;74(21):1724-31. doi: 10.1212/WNL.0b013e3181e04264.

PMID:
20498440
2.

Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Lev MH, Ozsunar Y, Henson JW, Rasheed AA, Barest GD, Harsh GR 4th, Fitzek MM, Chiocca EA, Rabinov JD, Csavoy AN, Rosen BR, Hochberg FH, Schaefer PW, Gonzalez RG.

AJNR Am J Neuroradiol. 2004 Feb;25(2):214-21. Erratum in: AJNR Am J Neuroradiol. 2004 Mar;25(3):B1.

3.

[Spatial delimitation of low grade oligodendrogliomas].

Pallud J, Devaux B, Nataf F, Roux FX, Daumas-Duport C.

Neurochirurgie. 2005 Sep;51(3-4 Pt 2):254-9. French.

PMID:
16292169
4.

Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate?

Muragaki Y, Chernov M, Maruyama T, Ochiai T, Taira T, Kubo O, Nakamura R, Iseki H, Hori T, Takakura K.

Minim Invasive Neurosurg. 2008 Oct;51(5):275-9. doi: 10.1055/s-0028-1082322. Epub 2008 Oct 14.

PMID:
18855292
5.

Platelet-derived growth factor expression correlates with tumor grade and proliferative activity in human oligodendrogliomas.

Majumdar K, Radotra BD, Vasishta RK, Pathak A.

Surg Neurol. 2009 Jul;72(1):54-60. doi: 10.1016/j.surneu.2008.10.001.

PMID:
19559929
6.

Quantitative characterization of the imaging limits of diffuse low-grade oligodendrogliomas.

Gerin C, Pallud J, Deroulers C, Varlet P, Oppenheim C, Roux FX, Chrétien F, Thomas SR, Grammaticos B, Badoual M.

Neuro Oncol. 2013 Oct;15(10):1379-88. doi: 10.1093/neuonc/not072. Epub 2013 Jun 14.

7.

Olig2 is useful in the differential diagnosis of oligodendrogliomas and extraventricular neurocytomas.

Okada M, Yano H, Hirose Y, Nakayama N, Ohe N, Shinoda J, Iwama T.

Brain Tumor Pathol. 2011 Apr;28(2):157-61. doi: 10.1007/s10014-011-0017-5. Epub 2011 Feb 11.

PMID:
21312066
8.

Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.

Xu M, See SJ, Ng WH, Arul E, Back MF, Yeo TT, Lim CC.

Neurosurgery. 2005 May;56(5):919-26; discussion 919-26.

PMID:
15854239
9.

Predictive value of multimodality MRI using conventional, perfusion, and spectroscopy MR in anaplastic transformation of low-grade oligodendrogliomas.

Hlaihel C, Guilloton L, Guyotat J, Streichenberger N, Honnorat J, Cotton F.

J Neurooncol. 2010 Mar;97(1):73-80. doi: 10.1007/s11060-009-9991-4. Epub 2009 Aug 29.

PMID:
19727562
10.

Diversity of glial cell components in pilocytic astrocytoma.

Tanaka Y, Sasaki A, Ishiuchi S, Nakazato Y.

Neuropathology. 2008 Aug;28(4):399-407. doi: 10.1111/j.1440-1789.2008.00896.x. Epub 2008 Feb 26.

PMID:
18312545
11.

Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.

Kleinschmidt-DeMasters BK, Hashizumi TL, Sze CI, Lillehei KO, Shroyer AL, Shroyer KR.

J Clin Pathol. 1998 Apr;51(4):284-93.

13.

Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.

Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, Wara WW, Larson DA, Sneed PK.

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1254-64.

PMID:
12128127
14.

Prognostic implication of histopathological, immunohistochemical and clinical features of oligodendrogliomas: a study of 89 cases.

Dehghani F, Schachenmayr W, Laun A, Korf HW.

Acta Neuropathol. 1998 May;95(5):493-504.

PMID:
9600596
15.

Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology.

Ikota H, Kinjo S, Yokoo H, Nakazato Y.

Acta Neuropathol. 2006 May;111(5):475-82. Epub 2006 Apr 6.

PMID:
16598485
16.

3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.

Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):126-37.

PMID:
15093908
17.

Serial stereotactic biopsies and CT scan in gliomas: correlative study in 100 astrocytomas, oligo-astrocytomas and oligodendrocytomas.

Daumas-Duport C, Monsaigneon V, Blond S, Munari C, Musolino A, Chodkiewicz JP, Missir O.

J Neurooncol. 1987;4(4):317-28.

PMID:
3553439
18.

Epileptogenic glioma in a 4-year-old child: a case report.

Muroi A, Takano S, Satomi K, Matsumura A.

Brain Tumor Pathol. 2010 Oct;27(2):127-31. doi: 10.1007/s10014-010-0274-8. Epub 2010 Nov 3.

PMID:
21046316
19.

Low grade gliomas: comparison of intraoperative ultrasound characteristics with preoperative imaging studies.

Le Roux PD, Berger MS, Wang K, Mack LA, Ojemann GA.

J Neurooncol. 1992 Jun;13(2):189-98.

PMID:
1432034
20.

Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.

Fayed N, Dávila J, Medrano J, Olmos S.

Eur J Radiol. 2008 Sep;67(3):427-33. doi: 10.1016/j.ejrad.2008.02.039. Epub 2008 Apr 28.

PMID:
18442889

Supplemental Content

Support Center